$4.78 Billion is the total value of BAIN CAPITAL INVESTORS LLC's 5 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CERE | CEREVEL THERAPEUTICS HLDNG I | $1,603,119,000 | -24.5% | 60,632,356 | 0.0% | 33.55% | +9.2% | |
| DSEY | DIVERSEY HLDGS LTD | $1,561,304,000 | -12.8% | 236,561,159 | 0.0% | 32.67% | +26.1% | |
| SGRY | SURGERY PARTNERS INC | $1,418,948,000 | -47.5% | 49,064,576 | 0.0% | 29.69% | -24.0% | |
| AVAH | AVEANNA HEALTHCARE HLDGS INC | $184,418,000 | -33.7% | 81,600,880 | 0.0% | 3.86% | -4.1% | |
| ADV | ADVANTAGE SOLUTIONS INC | $10,982,000 | -40.4% | 2,890,000 | 0.0% | 0.23% | -13.9% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Bain Capital Integral Investors 2008, L.P. #1
- Bain Capital Integral Investors 2006, LLC #2
- BCPE Seminole GP LLC #3
- BCPE Seminole Holdings LP #4
- Bain Capital Partners XII, LLC #5
- Bain Capital Fund XII, L.P. #6
- BCPE Perception GP, LLC #7
- BC Perception Holdings, LP #8
- Bain Capital Partners XI, L.P. #9
- Bain Capital Fund XI, L.P. #10
- BCPE Eagle GP, LLC #11
- BCPE Diamond GP, LLC #12
- BCPE Eagle Investor, LP #13
- BCPE Diamond Investor, LP #14
- Bain Capital Partners Europe IV, L.P. #15
- Bain Capital Europe Fund IV, L.P. #16
- BCPE Diamond Cayman Holding Ltd #17
- BCIP Associates IV, L.P. #18
- BCIP Associates IV (US), L.P. #19
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MICHAELS COS INC | 27 | Q1 2021 | 45.7% |
| GENPACT LIMITED | 26 | Q3 2019 | 43.3% |
| VERITIV CORP | 26 | Q4 2020 | 7.1% |
| SURGERY PARTNERS INC | 25 | Q3 2023 | 54.6% |
| ATENTO S A | 25 | Q4 2020 | 14.1% |
| BRIGHT HORIZONS FAM SOL IN D | 19 | Q4 2017 | 18.4% |
| QUINTILES TRANSNATIO HLDGS I | 18 | Q3 2017 | 15.1% |
| IQVIA HLDGS INC | 16 | Q3 2021 | 17.2% |
| VONAGE HLDGS CORP | 13 | Q2 2016 | 0.0% |
| CEREVEL THERAPEUTICS HLDNG, INC. | 12 | Q3 2023 | 42.1% |
View BAIN CAPITAL INVESTORS LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 4 | 2023-12-21 |
| 13F-HR | 2023-11-14 |
| 4 | 2023-10-18 |
| 13F-HR | 2023-08-14 |
| 4 | 2023-07-06 |
| 4 | 2023-06-12 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 4 | 2022-11-23 |
View BAIN CAPITAL INVESTORS LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.